Skip to main content
DNA Labs India

APC2 Gene Neurodevelopmental disorder, APC2-related NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

APC2 Gene Neurodevelopmental disorder, APC2-related NGS Genetic Test

Short Name: APC2 Gene NGS Test

Also known as: APC2 Gene Test, APC2-Related Neurodevelopmental Disorder Test, Adenomatous Polyposis Coli 2 Gene Test, APC2 Mutation Analysis, APC2 NGS Sequencing Test

APC2 Gene Neurodevelopmental disorder, APC2-related NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via the online portal, email, or WhatsApp.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the APC2 Gene Neurodevelopmental Disorder NGS Genetic Test is to identify pathogenic or likely pathogenic mutations in the APC2 gene that are responsible for neurodevelopmental abnormalities. This test aids in confirming a clinical diagnosis, differentiating APC2-related disorder from other neurodevelopmental conditions with overlapping features, facilitating genetic counselling for affected families, enabling carrier testing for at-risk family members, and guiding clinical management and intervention planning for the affected individual.

Test Code
1773
ICD Code
F89, Q87.89
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via the online portal, email, or WhatsApp.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Genetic counselling session is recommended prior to sample collection. A detailed clinical history and family pedigree chart of the patient should be prepared. No fasting is required. Ensure the patient is not acutely ill or has not received a recent blood transfusion within 4 weeks.

Method: Venipuncture

Step 2

Laboratory Analysis

A trained phlebotomist will collect 3-5 mL of venous blood in an EDTA (lavender top) tube. Alternatively, a single drop of blood on an FTA card or pre-extracted DNA may be submitted. The sample is labelled with patient details and transported under appropriate conditions.

Step 3

Report Delivery

The blood sample is processed and DNA is extracted in the laboratory. NGS sequencing is performed on the APC2 gene. Results are reviewed by a qualified geneticist and a detailed report is generated. Reports are typically available within 3 to 4 weeks and are delivered via the online portal, email, or WhatsApp.

Timeline: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via the online portal, email, or WhatsApp.

Patient Instructions

1
Before the Test:A clinical evaluation by a neurologist or geneticist is recommended to assess symptoms and determine if genetic testing is appropriate. A genetic counselling session should be conducted to discuss the test purpose, implications, and possible outcomes. A detailed family history and pedigree chart should be prepared. No fasting is required before sample collection.
2
During the Test:A blood sample (3-5 mL) is collected via venipuncture into an EDTA tube. Alternatively, a single drop of blood on an FTA card or extracted DNA can be used. The sample collection process is quick, minimally invasive, and similar to a routine blood draw. There are no special preparations or restrictions needed during sample collection.
3
After the Test:After sample collection, patients can resume normal activities immediately. The sample undergoes DNA extraction and NGS sequencing in the laboratory. Results are typically available within 3 to 4 weeks. A follow-up genetic counselling session is recommended after receiving results to discuss findings, implications, recurrence risk, and next steps for clinical management.

About This Test

Who Should Get This Test

The purpose of the APC2 Gene Neurodevelopmental Disorder NGS Genetic Test is to identify pathogenic or likely pathogenic mutations in the APC2 gene that are responsible for neurodevelopmental abnormalities. This test aids in confirming a clinical diagnosis, differentiating APC2-related disorder from other neurodevelopmental conditions with overlapping features, facilitating genetic counselling for affected families, enabling carrier testing for at-risk family members, and guiding clinical management and intervention planning for the affected individual.

How to Prepare

  • Collect 3-5 mL of venous blood in an EDTA (lavender top) tube
  • Alternatively, provide one drop of blood on an FTA card or pre-extracted DNA
  • Label the sample accurately with patient name, date of birth, and sample ID
  • Transport the sample at ambient room temperature
  • Ensure the sample reaches the laboratory within 48-72 hours of collection
  • Avoid hemolyzed or clotted samples

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"APC2 gene mutations can present with a wide spectrum of neurodevelopmental features. Early genetic diagnosis through NGS technology allows families to understand the underlying cause of their child's condition, plan appropriate interventions, and assess recurrence risk for future pregnancies. I recommend this test for any child presenting with unexplained developmental delay, intellectual disability, or autism-like features when initial workup has been inconclusive. Genetic counselling before and after the test is essential to help families interpret the results and make informed decisions about ongoing care and family planning."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL whole blood
ContainerEDTA (Lavender Top) Tube or FTA Card
Collection MethodVenipuncture

Sample Stability

Whole blood in EDTA tube: Stable for 48-72 hours at ambient room temperature (15-25°C)
Whole blood in EDTA tube: Stable for up to 7 days when refrigerated (2-8°C)
Extracted DNA: Stable for up to 6 months when stored at -20°C
Blood on FTA Card: Stable at ambient room temperature for extended periods when stored in sealed bags
Sample Rejection Criteria:
  • Hemolyzed or clotted blood samples
  • Samples with insufficient volume (less than 2 mL whole blood)
  • Improperly labelled or unlabelled samples
  • Samples received beyond the acceptable stability window
  • Contaminated samples or samples collected in incorrect tubes
  • Samples from patients who have received blood transfusions within the past 4 weeks without prior disclosure

Understanding Your Results

The results of the APC2 Gene Neurodevelopmental Disorder NGS Genetic Test are interpreted by a qualified clinical geneticist. The report will indicate whether pathogenic or likely pathogenic variants were detected in the APC2 gene. Variants are classified according to the American College of Medical Genetics and Genomics (ACMG) guidelines into five categories: Pathogenic, Likely Pathogenic, Variant of Uncertain Significance (VUS), Likely Benign, and Benign.
📊

Pathogenic variant detected

A mutation in the APC2 gene known to cause neurodevelopmental disorder was identified. This confirms the genetic diagnosis. Genetic counselling and clinical management planning are recommended.

📊

Likely pathogenic variant detected

A variant in the APC2 gene that is very likely disease-causing was identified. Further clinical correlation and family studies may be recommended. Genetic counselling is advised.

📊

Variant of Uncertain Significance (VUS)

A genetic change in the APC2 gene was identified, but there is insufficient evidence to determine whether it is disease-causing or benign. Further family studies and clinical follow-up may help clarify significance.

📊

Likely benign variant detected

A variant was identified in the APC2 gene that is unlikely to be related to the patient's neurodevelopmental phenotype. No action is typically required for this finding.

📊

No pathogenic variant detected

No disease-causing mutations were identified in the APC2 gene. This result does not completely exclude a genetic basis for the patient's condition, as mutations in other genes may be responsible.

⚠️ When to Consult a Doctor:

Consult your neurologist, clinical geneticist, or paediatrician if you or your child experiences delayed speech and language development, intellectual disability, features of autism spectrum disorder, poor motor coordination, seizures, or if there is a family history of neurodevelopmental disorders. A medical professional can evaluate the clinical signs and recommend appropriate genetic testing, including the APC2 Gene NGS Genetic Test.

Limitations

  • This test specifically targets the APC2 gene and does not detect mutations in other neurodevelopmental disorder-associated genes
  • Deep intronic mutations and large structural rearrangements may not be fully detected by standard NGS
  • Variants of Uncertain Significance (VUS) may be identified and cannot be definitively classified as pathogenic or benign at the time of reporting
  • A negative result does not completely exclude a genetic basis for the neurodevelopmental phenotype
  • Results should be interpreted in the context of clinical findings and family history by a qualified geneticist or neurologist

Risks & Considerations

  • Minimal physical risk associated with blood draw, including minor bruising, soreness, or infection at the puncture site
  • Potential psychological impact of receiving genetic test results, including anxiety or emotional distress
  • Risk of identifying Variants of Uncertain Significance (VUS) that may cause uncertainty
  • Potential implications for family members who may carry the same genetic variant
  • Possible insurance or privacy concerns related to genetic information disclosure

Interfering Factors

  • Hemolyzed blood samples may affect DNA extraction quality
  • Recent blood transfusion within the past 4 weeks may interfere with results
  • Insufficient sample volume may reduce sequencing coverage
  • Contaminated samples may produce inaccurate results

Compare With Similar Tests

TestAPC2 Gene Neurodevelopmental disorder, APC2-related NGS Genetic TestSanger SequencingChromosomal Microarray (CMA)Whole Exome Sequencing (WES)Neurodevelopmental Gene Panel
ComparisonAPC2 Gene Neurodevelopmental disorder, APC2-related NGS Genetic Test

Frequently Asked Questions

What is APC2 Gene Neurodevelopmental Disorder?
APC2 Gene Neurodevelopmental Disorder is a rare genetic condition caused by mutations in the APC2 (Adenomatous Polyposis Coli 2) gene. This gene is involved in brain development and neuronal signalling. Mutations can lead to a range of neurodevelopmental challenges including delayed speech, intellectual disability, autism spectrum features, poor motor coordination, and seizures.
What are the common symptoms of APC2 Gene Neurodevelopmental Disorder?
Common symptoms include delayed speech and language development, poor motor skills, difficulty with social interaction, intellectual disability, features of autism spectrum disorder, and seizures. The severity and combination of symptoms can vary significantly among affected individuals. Not all individuals with APC2 gene mutations will exhibit all symptoms.
How is APC2 Gene Neurodevelopmental Disorder diagnosed?
Diagnosis is confirmed through genetic testing using Next-Generation Sequencing (NGS) technology. NGS enables comprehensive analysis of the APC2 gene to identify pathogenic mutations. A clinical evaluation by a neurologist or geneticist, along with a detailed family history, is essential before ordering the genetic test.
What is Next-Generation Sequencing (NGS) technology?
Next-Generation Sequencing (NGS) is an advanced genetic testing technology that allows rapid and comprehensive sequencing of targeted genes or the entire genome. NGS is highly sensitive and specific, capable of detecting a wide range of genetic variations including point mutations, small insertions and deletions in the APC2 gene.
What sample is required for the APC2 Gene NGS Genetic Test?
The test requires a blood sample (3-5 mL) collected in an EDTA (lavender top) tube. Alternatively, extracted DNA or a single drop of blood on an FTA card can also be used. Free home sample collection is available across India.
How much does the APC2 Gene NGS Genetic Test cost in India?
The cost of the APC2 Gene Neurodevelopmental Disorder NGS Genetic Test at DNA Labs India is ?20,000 (Indian Rupees). This includes sample collection, NGS sequencing, genetic analysis, and report generation. Free home sample collection is available at no additional cost.
How long does it take to get the results of the APC2 Gene test?
Results are typically available within 3 to 4 weeks from the date the sample is received at the laboratory. Reports are delivered via the online portal, email, or WhatsApp for your convenience.
Is genetic counselling required before taking the APC2 Gene test?
Yes, genetic counselling is strongly recommended both before and after the test. Pre-test counselling helps you understand the purpose of the test, its implications, possible outcomes, and the impact of results on family members. Post-test counselling helps interpret the results and plan next steps.
Can the APC2 Gene NGS test be used for screening other family members?
Yes. If a pathogenic or likely pathogenic variant is identified in an affected individual, targeted testing can be offered to other family members to determine their carrier status or risk of being affected. This is particularly useful for family planning and early intervention.
Is the APC2 Gene NGS Genetic Test available across India?
Yes. DNA Labs India offers free home sample collection for the APC2 Gene NGS Genetic Test in numerous cities across India including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, Jaipur, Lucknow, Chandigarh, and many more. Online booking is available for convenient scheduling.
What happens if the test result is positive for an APC2 gene mutation?
If a pathogenic or likely pathogenic variant is detected, a genetic counselling session will help you understand the diagnosis, disease implications, available supportive treatments, and recurrence risk for family members. Your geneticist or neurologist will guide you on clinical management and intervention strategies.
Is the APC2 Gene NGS Genetic Test covered by health insurance in India?
Coverage for genetic testing varies by insurance provider and policy. Most government schemes such as PMJAY, CGHS, ECHS, and ESIC may not routinely cover advanced genetic testing. Private insurance coverage depends on individual policies. It is recommended to check with your insurance provider for pre-authorization before scheduling the test.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.